Eric K. Nakakura

7.2k total citations
95 papers, 2.0k citations indexed

About

Eric K. Nakakura is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Eric K. Nakakura has authored 95 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 47 papers in Epidemiology and 27 papers in Surgery. Recurrent topics in Eric K. Nakakura's work include Neuroendocrine Tumor Research Advances (44 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Neuroblastoma Research and Treatments (25 papers). Eric K. Nakakura is often cited by papers focused on Neuroendocrine Tumor Research Advances (44 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Neuroblastoma Research and Treatments (25 papers). Eric K. Nakakura collaborates with scholars based in United States, Japan and Jordan. Eric K. Nakakura's co-authors include Emily K. Bergsland, M.A. Choti, Barry D. Nelkin, Douglas W. Ball, Robert S. Warren, Michael Borges, Virote Sriuranpong, D. Neil Watkins, Grace Kim and Douglas Hanahan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Eric K. Nakakura

89 papers receiving 2.0k citations

Peers

Countries citing papers authored by Eric K. Nakakura

Since Specialization

Citations

This map shows the geographic impact of Eric K. Nakakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric K. Nakakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric K. Nakakura more than expected).

Fields of papers citing papers by Eric K. Nakakura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric K. Nakakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric K. Nakakura. The network helps show where Eric K. Nakakura may publish in the future.

Co-authorship network of co-authors of Eric K. Nakakura

This figure shows the co-authorship network connecting the top 25 collaborators of Eric K. Nakakura. A scholar is included among the top collaborators of Eric K. Nakakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric K. Nakakura. Eric K. Nakakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with grade progression in pancreatic neuroendocrine tumors 2025 ·Endocrine Related Cancer ·Stephanie J. Wang, (unknown), Nancy M. Joseph, (unknown), Sheila Lindsay, (unknown), Eric K. Nakakura, Li Zhang, Emily K. Bergsland	2
2	Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score‐Matched Analysis 2025 ·Journal of Surgical Oncology ·Paul Wong, (unknown), Tommaso Pollini, (unknown), (unknown), L. Aguilar, (unknown), Lucas W. Thornblade, Mohamed A. Adam, Adnan Alseidi, Carlos U. Corvera, Kenzo Hirose, Kimberly S. Kirkwood, Eric K. Nakakura, Ajay V. Maker	0
3	Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors 2024 ·World Journal of Surgical Oncology ·Paul Wong, Andrew D. Wisneski, Katy K. Tsai, Tammy T. Chang, Kenzo Hirose, Eric K. Nakakura, Adil Daud, Ajay V. Maker, Carlos U. Corvera	2
4	Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients 2024 ·Journal of Gastrointestinal Surgery ·Daniel Hoffman, Amir Ashraf‐Ganjouei, (unknown), (unknown), (unknown), Alexa Glencer, Carlos U. Corvera, Kimberly S. Kirkwood, Adnan Alseidi, Mohamed A. Adam, Ajay V. Maker, Kenzo Hirose, Ryutaro Hirose, Eric K. Nakakura	0
5	National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis 2024 ·The American Journal of Surgery ·Megan Casey, (unknown), (unknown), Jane Wang, Amir Ashraf‐Ganjouei, Francesca Tozzi, Nikdokht Rashidian, (unknown), Carlos U. Corvera, Eric K. Nakakura, Adnan Alseidi, Mohamed A. Adam	1
6	Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment 2024 ·Clinical Cancer Research ·Aparna R. Parikh, (unknown), (unknown), Thereasa A. Rich, Kristin S. Price, Sonia Patel, Li Zhang, (unknown), Mikaela Esquivel, (unknown), (unknown), Victoria M. Raymond, Carlos U. Corvera, Kenzo Hirose, Eric K. Nakakura, Ryan B. Corcoran, Katherine Van Loon, Chloé E. Atreya	10
7	Enucleation of Neuroendocrine Liver Metastases 2024 ·Journal of Gastrointestinal Surgery ·(unknown), Yosuke Kasai, Eric K. Nakakura	0
8	Robotic-assisted endoluminal gastric leiomyoma resection: a novel surgical technique for benign gastroesophageal junction tumors 2024 ·Chinese Clinical Oncology ·(unknown), Amir Ashraf‐Ganjouei, Jane Wang, (unknown), Eric K. Nakakura, Adnan Alseidi, Mohamed A. Adam	1
9	Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data 2023 ·PLoS ONE ·(unknown), Luika Timmerman, Aras N. Mattis, Kan Toriguchi, Yosuke Kasai, Carlos U. Corvera, Eric K. Nakakura, Kenzo Hirose, David B. Donner, Robert S. Warren, (unknown)	1
10	National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kenzo Hirose, (unknown), Kimberly S. Kirkwood, Ajay V. Maker, Carlos U. Corvera, Eric K. Nakakura, Adnan Alseidi, Mohamed A. Adam	5
11	Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis 2021 ·Annals of Surgical Oncology ·(unknown), (unknown), Joseph A. Lin, (unknown), (unknown), Kenzo Hirose, Eric K. Nakakura, Carlos U. Corvera, Julie Ann Sosa, Ankit Sarin, Kimberly S. Kirkwood, Adnan Alseidi, Mohamed A. Adam	9
12	Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era 2020 ·Journal of Surgical Research ·Andrew D. Wisneski, Chengshi Jin, Chiung‐Yu Huang, Robert S. Warren, Kenzo Hirose, Eric K. Nakakura, Carlos U. Corvera	14
13	A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors 2018 ·Molecular Cancer Therapeutics ·Chester E. Chamberlain, Michael S. German, Katherine Yang, Jason Wang, Henry F. VanBrocklin, (unknown), Kevan M. Shokat, Gregory S. Ducker, Grace Kim, Byron Hann, David B. Donner, Robert S. Warren, Alan P. Venook, Emily K. Bergsland, Danny Lee, Yucheng Wang, Eric K. Nakakura	34
14	Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? 2016 ·Journal of Surgical Oncology ·Sunhee S. Kim, Eric K. Nakakura, Zhen J. Wang, Grace Kim, Carlos U. Corvera, Hobart W. Harris, Kimberly S. Kirkwood, Ryutaro Hirose, Margaret A. Tempero, Andrew H. Ko	30
15	Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures 2011 ·World Journal of Surgical Oncology ·William W. Tseng, Sam C. Wang, Charles M. Eichler, Robert S. Warren, Eric K. Nakakura	30
16	Compound Muscle Action Potentials and Spontaneous Electromyography Can be Used to Identify and Protect the Femoral Nerve During Resection of Large Retroperitoneal Tumors 2008 ·Annals of Surgical Oncology ·Lanjun Guo, John P. Clark, Robert S. Warren, Eric K. Nakakura	1
17	Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells 2006 ·Cancer Research ·Christopher J. Strock, Jong‐In Park, Eric K. Nakakura, G. Steven Bova, John T. Isaacs, Douglas W. Ball, Barry D. Nelkin	128
18	Regulation of Neuroendocrine Differentiation in Gastrointestinal Carcinoid Tumor Cells by Notch Signaling 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Eric K. Nakakura, Virote Sriuranpong, Muthusamy Kunnimalaiyaan, Edward C. Hsiao, Kornel E. Schuebel, Michael Borges, Ning Jin, Brendan Collins, Barry D. Nelkin, Herbert Chen, Douglas W. Ball	97
19	Notch Signaling Induces Rapid Degradation of Achaete-Scute Homolog 1 2002 ·Molecular and Cellular Biology ·Virote Sriuranpong, Michael Borges, (unknown), Eric K. Nakakura, D. Neil Watkins, Christine M. Blaumueller, Barry D. Nelkin, Douglas W. Ball	139
20	Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells 2001 ·Molecular Brain Research ·Eric K. Nakakura, D. Neil Watkins, Virote Sriuranpong, Michael Borges, Barry D. Nelkin, Douglas W. Ball	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact